Hjem › Leverkreft › Texas › Houston
Kliniske studier for Leverkreft i Houston, TX
14 studier for Leverkreft søker deltakere på steder i og rundt Houston (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
National Liver Cancer Screening Trial
RekruttererFase 4
- Baylor College of Medicine, Houston
CREO - Microwave Ablation Feasibility Study
Rekrutterer
- Memorial Hermann-Texas Medical Center, Houston
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
RekruttererFase 1
- UT MD Anderson, Houston
Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
RekruttererFase 1
- Texas Children's Hospital, Houston
Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- MD Anderson Cancer Center, Houston
A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
RekruttererFase 1
- MD Anderson Cancer Center, Houston
- NEXT Houston, Houston
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
RekruttererFase 1
- Clinical Trial Site, Houston
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Rekrutterer
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
RekruttererFase 1/2
- MD Anderson Cancer Center, Houston
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
RekruttererFase 1/2
- MD Anderson Cancer Center, Houston
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
RekruttererObservasjonsstudie
- Md Anderson Cancer Center, Houston
Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma
RekruttererFase 2
- Baylor College of Medicine, Houston
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Houston
Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria
RekruttererFase 4
- Houston Methodist Research Institute, Houston
Leverkreft-studier i andre byer
- Los Angeles, CA11 studier
- Cleveland, OH11 studier
- Dallas, TX10 studier
- Boston, MA9 studier
- Chicago, IL8 studier
- St. Louis, MO8 studier
- Durham, NC7 studier
- Philadelphia, PA7 studier
- Washington, DC6 studier
- San Francisco, CA6 studier
- Orange, CA6 studier
- New York City, NY6 studier
Andre studier i Houston
- Ikke-småcellet lungekreft145 studier
- Brystkreft126 studier
- Kreft (alle typer)121 studier
- Metastatisk kreft104 studier
- Kolorektal kreft102 studier
- Eggstokkreft89 studier
- Akut myelogen leukemi85 studier
- Lungekreft78 studier
- Prostatakreft76 studier
- Endometriekreft68 studier
- Pankreaskreft61 studier
- Melanom59 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.